SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-22-041024
Filing Date
2022-03-31
Accepted
2022-03-31 16:10:17
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM tm2210362-1_posam.htm POS AM 647781
2 EXHIBIT 23.3 tm2210362d2_ex23-3.htm EX-23.3 2663
3 EXHIBIT 23.4 tm2210362d2_ex23-4.htm EX-23.4 3615
4 EX-FILING FEES tm2210362d2_ex-filingfees.htm EX-FILING FEES 53432
5 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22590
6 GRAPHIC tm2210362d1-tbl_resea4clr.jpg GRAPHIC 95558
7 GRAPHIC tm2210362d1-tbl_exter4clr.jpg GRAPHIC 96910
8 GRAPHIC tm2210362d1-tbl_mater4clr.jpg GRAPHIC 174463
9 GRAPHIC tm2210362d1-tbl_earl4clr.jpg GRAPHIC 113235
  Complete submission text file 0001104659-22-041024.txt   1401727
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-262050 | Film No.: 22792562
SIC: 2834 Pharmaceutical Preparations